A Phase 2, Randomized, Double-Blind, Multicenter Trial to Evaluate the Safety and Efficacy of Three Dosing Regimens of Isavuconazole Compared With Fluconazole in Patients With Uncomplicated Esophageal Candidiasis

Antimicrobial Agents and Chemotherapy - United States

doi 10.1128/aac.04586-14